Related Experiment Videos
Central anticholinergic syndrome in a child undergoing circumcision
U Schultz1, R Idelberger, R Rossaint
1Klinik für Anästhesiologie, Universitätsklinikum der RWTH, Aachen, Germany. uta.schultz@post.rwth-aachen.de
Acta Anaesthesiologica Scandinavica
|April 12, 2002
Summary
Central anticholinergic syndrome (CAS) can cause deep sedation and airway obstruction in children after surgery. Prompt physostigmine administration effectively reversed these symptoms in a pediatric patient.
Area of Science:
- Anesthesiology
- Pediatric Critical Care
- Clinical Toxicology
Background:
- Central anticholinergic syndrome (CAS) is a potentially serious condition resulting from excessive blockade of muscarinic acetylcholine receptors.
- While recognized in adults, pediatric cases, particularly post-anesthesia, are less commonly reported.
- Identifying CAS is crucial for timely and effective management in pediatric surgical patients.
Observation:
- An 8-year-old boy developed profound sedation, unresponsiveness, and upper airway obstruction post-elective surgery.
- These symptoms were attributed to central anticholinergic syndrome, likely due to anesthetic agents with anticholinergic properties.
- Reduced muscular tone of the upper airway significantly contributed to the observed airway obstruction.
Findings:
- The clinical presentation of deep sedation and airway compromise in this pediatric patient was consistent with CAS.
- Intravenous administration of physostigmine, a reversible acetylcholinesterase inhibitor, led to immediate resolution of all symptoms.
- This case highlights the efficacy of physostigmine in reversing anticholinergic toxicity in a pediatric surgical context.
Implications:
- Central anticholinergic syndrome should be considered in the differential diagnosis of prolonged sedation or unexplained airway obstruction in pediatric patients following general anesthesia.
- Awareness of CAS and prompt recognition are vital for pediatric anesthesiologists and critical care physicians.
- Physostigmine serves as a critical antidote for reversing severe anticholinergic effects in children, preventing prolonged recovery and potential complications.